Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
2024-02-13 06:13 am Purchase | 2023-12-31 | 13G | MacroGenics, Inc. MGNX | BB Biotech AG | 9,929,963 16.000% | 1,000,000![]() (+11.20%) | Filing History |
2024-02-13 06:09 am Sale | 2023-12-31 | 13G | Ionis Pharmaceuticals, Inc. IONS | BB Biotech AG | 8,590,000 6.000% | -1,045,000![]() (-10.85%) | Filing History |
2024-02-13 06:07 am Sale | 2023-12-31 | 13G | Agios Pharmaceuticals, Inc. AGIO | BB Biotech AG | 4,000,000 7.200% | -30,792![]() (-0.76%) | Filing History |
2024-02-13 06:06 am Purchase | 2023-12-31 | 13G | Revolution Medicines, Inc. RVMD | BB Biotech AG | 5,046,700 3.100% | 269,138![]() (+5.63%) | Filing History |
2024-02-13 06:05 am Purchase | 2023-12-31 | 13G | Black Diamond Therapeutics, Inc. BDTX | BB Biotech AG | 8,517,839 16.500% | 3,140,000![]() (+58.39%) | Filing History |
2024-02-13 06:04 am Unchanged | 2023-12-31 | 13G | ESSA Pharma Inc. EPIX | BB Biotech AG | 7,879,583 17.900% | 0 (Unchanged) | Filing History |
2024-01-24 3:46 pm Purchase | 2024-01-19 | 13G | Esperion Therapeutics, Inc. ESPR | BB Biotech AG | 9,194,064 5.100% | 5,000,000![]() (+119.22%) | Filing History |
2024-01-24 3:21 pm Unchanged | 2023-12-31 | 13G | Esperion Therapeutics, Inc. ESPR | BB Biotech AG | 4,194,064 3.700% | 0 (Unchanged) | Filing History |
2023-02-17 5:23 pm Purchase | 2023-02-09 | 13G | Sage Therapeutics, Inc. SAGE | BB Biotech AG | 3,100,278 5.200% | 150,000![]() (+5.08%) | Filing History |
2023-02-14 4:20 pm Sale | 2022-12-31 | 13G | Kezar Life Sciences, Inc. KZR | BB Biotech AG | 300,000 4.400% | -191,815![]() (-39.00%) | Filing History |
2023-02-14 4:18 pm Sale | 2022-12-31 | 13G | Generation Bio Co. GBIO | BB Biotech AG | 3,608,280 6.100% | -244,900![]() (-6.36%) | Filing History |
2023-02-14 4:18 pm Sale | 2022-12-31 | 13G | Esperion Therapeutics, Inc. ESPR | BB Biotech AG | 4,194,064 5.700% | -283,900![]() (-6.34%) | Filing History |
2023-02-14 4:18 pm Sale | 2022-12-31 | 13G | Mersana Therapeutics, Inc. MRSN | BB Biotech AG | 4,066,200 4.100% | -68,800![]() (-1.66%) | Filing History |
2023-02-14 4:17 pm Sale | 2022-12-31 | 13G | Myovant Sciences Ltd. MYOV | BB Biotech AG | 5,872,639 6.000% | -249,400![]() (-4.07%) | Filing History |
2023-02-14 4:16 pm Sale | 2022-12-31 | 13G | Sage Therapeutics, Inc. SAGE | BB Biotech AG | 2,950,278 5.000% | -219,826![]() (-6.93%) | Filing History |
2023-02-14 4:15 pm Purchase | 2022-12-31 | 13G | Revolution Medicines, Inc. RVMD | BB Biotech AG | 4,777,562 5.400% | 175,000![]() (+3.80%) | Filing History |
2023-02-14 4:14 pm Purchase | 2022-12-31 | 13G | Black Diamond Therapeutics, Inc. BDTX | BB Biotech AG | 5,377,839 14.800% | 1,389,437![]() (+34.84%) | Filing History |
2023-02-14 4:14 pm Sale | 2022-12-31 | 13G | Scholar Rock Holding Corporation SRRK | BB Biotech AG | 2,132,725 4.100% | -142,400![]() (-6.26%) | Filing History |
2023-02-14 4:13 pm Purchase | 2022-12-31 | 13G | Molecular Templates, Inc. MTEM | BB Biotech AG | 746,134 19.900% | 26,667![]() (+3.71%) | Filing History |
2023-02-14 4:12 pm Purchase | 2022-12-31 | 13G | ESSA Pharma Inc. EPIX | BB Biotech AG | 7,879,583 17.900% | 2,863,769![]() (+57.09%) | Filing History |